JAMA Cardiology·16 SepEfficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical TrialRandomised trial in 17,604 peopleSemaglutidePaper
ADA Scientific Sessions 2025 Abstract·13 JunGlycemic Outcomes When Switching to iGlarLixi from Premixed Insulin (PI) in People with Type 2 Diabetes (T2D) by iGlarLixi Pen Subgroups—Post Hoc Analysis of Soli-SWITCHTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunEarly Glycemic Improvement When Switching to iGlarLixi from Premixed Insulins (PI) in Adults with Type 2 Diabetes (T2D)—A Post Hoc Analysis of Soli-SWITCHTrial in peopleInterventionsPaper